A Missed Opportunity in Expanded Access Limits Real-World Insights
An expanded access protocol for gemtuzumab ozogamicin gathered only safety data, no efficacy data, limiting insights into real-world use.
General Oncology
Negative Effects of Exercise Intolerance in Long-Term Cancer Survivors
Long-term survivors of childhood cancers with exercise intolerance may have emotional distress, less social role achievement, and worse HRQOL.
Immunotherapy May Increase Risk for Hospitalization, Severe Respiratory Illness From COVID-19
Patients with cancer and COVID-19 had high rates of hospitalization and/or respiratory illness, particularly among those taking immunotherapy or those older than 65 years.
Active Anticancer Treatment Associated With Poor COVID-19 Prognosis
Patients with cancer are more susceptible to infection with SARS-CoV-2, and patients receiving active anticancer treatment have a poorer prognosis.
Age, Residence, Other Factors Associated With Palliative Care Consultations in Patients With Advanced Cancer
Several factors were found to affect whether patients with cancer received a palliative care consultation at a tertiary care center.
New ASCO Clinical Guidelines on Management of Cancer Cachexia
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
First Guidelines for Providing Oncology Pharmacy Services in COVID-19
The first set of guidelines for providing oncology pharmacy services to cancer patients during the COVID-19 pandemic was recently published.
Bodyweight-Based Dosing of Nivolumab Results in Wastage
A review of practices prior to a change in nivolumab dosing demonstrated that bodyweight dosing resulted in a 6.1% rate of wastage at a significant cost compared with a fixed dose of 240 mg per dose.
Crysvita Approved for Treatment of Tumor-Induced Osteomalacia
The FDA has approved Crysvita® (burosumab-twza; Ultragenyx) for the treatment of fibroblast growth factor 23 (FGF23)-related hypophosphatemia in tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors that cannot be curatively resected or localized in patients aged ≥2 years.
US Medical Cancer Care Costs Substantial, Expected to Increase
Costs of care for patients with cancer was found to vary based on stage and site of disease.
-
Loading...
-
Loading...
Next post in General Oncology
